Roche Diagnostics Breaks Ground on New Learning and Development Center
Mayor Greg Ballard joins company and community leaders to break ground on
first major element of recently announced $300 million site transformation
INDIANAPOLIS, Nov. 14, 2012
INDIANAPOLIS, Nov. 14, 2012 /PRNewswire/ --Mayor Greg Ballard today joined
Roche Diagnostics President and CEO Jack Phillips as well as other Roche
executives and community leaders to break ground on the company's new Learning
and Development Center. The center is the first element of a $300 million site
transformation investment that was announced in June 2012. The city of
Indianapolis and the Indiana Economic Development Corporation offered Roche
tax abatements, tax credits and training grants to support Roche's investment.
"Roche's decision to grow and invest in Indianapolis is a testament to our
strength as a life sciences center," said Mayor Ballard, who participated in
the ceremony held on the company's campus near the intersection of 96th Street
and Interstate 69. "They've been an important part of our life sciences
heritage for nearly 50 years now, and this expansion signals an important
commitment to the region."
"Central Indiana has been our home since 1964 and we are here to stay," said
Jack Phillips, president and CEO of Roche Diagnostics, adding that the
company's history and growth in the region is due in part to the community's
outstanding workforce and partnerships with the state and city that have
enhanced job creation.
The company, a leader in pharmaceuticals and diagnostics, will invest $300
million during the next 10 years at its North American headquarters on the
northeast side of Indianapolis. The capital investments will support the
company's growing diagnostics and diabetes care businesses. The new Learning
and Development Center will host the training of more than 1,500 customers
from across the nation each year.
"It is fitting that the new Learning and Development Center is the first phase
of our site transformation because it reflects our commitment to always put
the customer first," said Phillips.
The ceremony also marked the first public unveiling of the new building's
renderings, which when completed will be one of the most unique structures in
Central Indiana.The center will employ a distinct architectural style
consistent with the company's European heritage.
"As a key piece of our North American Headquarters, the new Learning and
Development Center will serve as a hub and gateway for worldwide operations,"
said Phillips. "We felt that it was important for the building to reflect our
global influence, right here in Indianapolis."
Headquartered in Basel, Switzerland, Roche is a leader in research-focused
healthcare with combined strengths in pharmaceuticals and diagnostics. Roche
is the world's largest biotech company with truly differentiated medicines in
oncology, virology, inflammation, metabolism and CNS. Roche is also the world
leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer
in diabetes management. Roche's personalized healthcare strategy aims at
providing medicines and diagnostic tools that enable tangible improvements in
the health, quality of life and survival of patients. In 2011, Roche had over
80,000 employees worldwide and invested over 8 billion Swiss francs in R&D.
The Group posted sales of 42.5 billion Swiss francs. Genentech, United States,
is a wholly owned member of the Roche Group. Roche has a majority stake in
Chugai Pharmaceutical, Japan. For more information: www.roche.com or
All trademarks used or mentioned in this release are protected by law.
For further information, please contact:
Director, Corporate Communications
Roche Diagnostics Corporation
SOURCE Roche Diagnostics
Press spacebar to pause and continue. Press esc to stop.